YG
Vice President, Scientific & Regulatory Affai...
Get the full picture
Sign in to uncover key details.
NeuroGenesis
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
410 White Spruce Blvd, Rochester, New Yo...Website
www.neurogenesis-cell.comRevenue
<$5 MillionIndustry
About NeuroGenesis
NeuroGenesis is a clinical stage cellular therapy company dedicated to developing innovative treatments for neurodegenerative diseases, specifically targeting conditions like progressive multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). Their proprietary NG CELL platform utilizes enhanced bone marrow stem cells to create remyelinating and regenerative biofactory cells that aim to slow or halt neurodegeneration. The company focuses on delivering sustained levels of therapeutic proteins to promote the regeneration of myelin and neuronal cells, improving the quality of life for patients. With a strong emphasis on advanced cellular therapy, NeuroGenesis is positioned to pioneer new hope and cures in the field of neurodegenerative disease treatment.Explore more
NeuroGenesis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to NeuroGenesis
Compare insights from companies similar to NeuroGenesis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NeuroGenesis Tech Stack
A closer look at the technologies used by NeuroGenesis
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding NeuroGenesis
Sign Up For FreeTo access detailed company insights
NeuroGenesis is a clinical stage cellular therapy company dedicated to developing innovative treatments for neurodegenerative diseases, specifically targeting conditions like progressive multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). Their proprietary NG CELL platform utilizes enhanced bone marrow stem cells to create remyelinatin... Read More
